1. Fibro-Mark: a panel of laboratory parameters for predicting significant fibrosis in chronic hepatitis C patients. Issue 1 (2nd January 2018) Authors: Attallah, AM; Omran, D; Omran, MM; Albannan, MS; Zayed, RA; Saif, S; Farid, A; Hassany, M; Yosry, A Journal: British journal of biomedical science Issue: Volume 75:Issue 1(2018) Page Start: 19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4. Issue 4 (2nd October 2018) Authors: Attallah, AM; Omran, D; Marie, M S; Abdelrazek, Mohamed; Salama, A; El Essawey, R; Mobarak, L; Maklad, S; Omar, A Journal: British journal of biomedical science Issue: Volume 75:Issue 4(2018) Page Start: 157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Toll-like receptor 7 mRNA is reduced in hepatitis C-based liver cirrhosis and hepatocellular carcinoma, out-performs alpha-fetoprotein levels, and with age and serum aspartate aminotransferase is a new diagnostic index. Issue 1 (2nd January 2021) Authors: Mohamed, AA; Omran, D; El-Feky, S; Darwish, H; Kassas, AEL; Farouk, A; Ezzat, O; Abdo, SM; Zahran, FE; El-Demery, A; Omran, MM Journal: British journal of biomedical science Issue: Volume 78:Issue 1(2021) Page Start: 18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗